Detection of EGFR and K-ras gene mutations in serum of non-small cell lung cancer patients

Detection of EGFR and K-ras gene mutations in serum of non-small cell lung cancer patients - Detection of EGFR and K-ras gene mutations in serum

Status

Active, not recruiting

Phases

Phase 2

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000006762

Enrollment

320

Registered

2011-11-24

Start date

2011-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenocarcinoma of the lung

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Treatment-naive patients with lung adenocarcinoma EGFR of which will be tested

Exclusion criteria

Exclusion criteria: Nothing

Design outcomes

Primary

Measure	Time frame
Sensitivity and specificity of evaluation of EGFR and K-ras gene mutation with plasma	—

Secondary

Measure	Time frame
Correlation between EGFR and K-ras gene mutation evaluated with plasma	—

Countries

Japan

Contacts

Public ContactFumio Imamura

Osaka Medical Center for Cancer and Cardiovascular Diseases Department of Thoracic Oncology

imamura-fu@mc.pref.osaka.jp+81-6-6972-1181

Outcome results